Infants and neonates are more vulnerable to more severe COVID-19 disease than older children

Objectives:
What are the clinical characteristics of COVID-19 in neonates and children under one year of age?

Study design:
This review article included 18 papers covering 160 infants. One paper was from Vietnam and the other 17 were from China: 8 were cross-sectional studies, 8 were case reports, 1 was a case series and 1 was a prospective cohort study.

Results and conclusions:   
The investigators found the most common clinical symptoms were fever (54%) and cough (33%).

Compared to adults, children and/or adolescents have a mild COVID-19 course with a good prognosis

Objectives:
What are the overall prevalence of clinical signs, symptoms and radiological findings in children and/or adolescents with COVID-19?

Study design:
This review article included 19 eligible studies for a total of 2,855 children and/or adolescents with COVID-19. Mean age was 6.9 ± 7.0 years; 50.3% males.

Routine use of systemic glucocorticoids for patients with COVID-19 cannot be recommended

Objectives:
Glucocorticoids are widely used in the treatment of various pulmonary inflammatory diseases, but they are also often accompanied by significant adverse reactions. Published guidelines point out that low dose and short duration systemic glucocorticoid therapy may be considered for patients with rapidly progressing coronavirus disease 2019 (COVID-19) while the evidence is still limited. Therefore, this review article has been conducted.

Iron fortification increases haemoglobin concentration during pregnancy

Objectives:
Micronutrients’ deficiency is a common phenomenon among a majority of the population residing in the low- and middle-income countries (LMICs) especially among women and children. Given the widespread prevalence of micronutrients’ deficiency in LMICs, iron-fortified foods could be of potential benefits for both the mother and the development of fetus. Therefore, this review article has been conducted.

Fever, respiratory symptoms and gastrointestinal manifestations are most common among children with COVID-19

Objectives:
Knowledge about COVID-19 in children is limited due to the paucity of reported data. The pediatric age group comprises only less than 5% of total COVID-19 worldwide. Therefore, large studies in this population are unlikely in the immediate future. Therefore, this review article has been conducted.